As of 2017, the optimal way to treat<unk>  remains controversial. Analgesics may be needed for the abdominal and joint pains. Wound care is warranted if the skin death and ulcerations occur. It is uncertain as to whether<unk>  needs treatment beyond controlling the symptoms. Most people do not receive therapy because of the high spontaneous recovery rate. Experts disagree on whether to routinely use corticosteroids as treatment for<unk> . However, if they are given early in the disease episode, the duration of symptoms may be shortened, and abdominal pain can improve significantly. Moreover, the chance of severe kidney problems may be reduced. A systematic review did not find any evidence that steroid treatment (prednisone) is effective at decreasing the likelihood of developing long-term kidney disease. Evidence of worsening kidney damage would normally prompt a kidney biopsy. Treatment may be indicated on the basis of the appearance of the biopsy sample; various treatments may be used, ranging from steroids by mouth to a combination of intravenous methylprednisolone (steroid), cyclophosphamide and dipyridamole followed by prednisone. Other regimens include steroids/azathioprine, and steroids/cyclophosphamide (with or without heparin and warfarin). Intravenous immunoglobulin (IVIG) is occasionally used. There is no good evidence that treating children who have<unk>  with antiplatelet agent prevents persistent kidney disease. There is also no evidence that treating children or adults with cyclophosphamide prevents severe kidney disease. Heparin treatment is not justified.
Henoch–Schönlein purpura
Chronic testicular pain
Amyloid purpura
Testicular pain
Golfer's vasculitis
Hennekam syndrome
Roussy–Lévy syndrome
Solar purpura